Eisai Adopts 340B Contract Pharmacy Restrictions, Pfizer and GSK Update Their Limits
Japanese pharmaceutical manufacturer Eisai will restrict 340B pricing on six drugs when dispensed by hospitals’ contract pharmacies. It is the [...]
*Sign up for news summaries and alerts from 340B Report